Cipla
Bharat Mahal is an experienced finance professional with a career spanning over a decade in the pharmaceutical and manufacturing sectors. Currently serving as an Assistant Manager in Finance & Accounts at Cipla since November 2017, Bharat Mahal has previously held positions as a Junior Officer at Glenmark Pharmaceuticals Limited and as an Assistant Officer at Emami Paper Mills Ltd. Key areas of expertise include finance and accounts management, accounts payable, bank reconciliation, trade finance, and taxation, along with proficiency in SAP FI/CO. Bharat Mahal holds a Master in Commerce in Finance and an MBA in Finance, both obtained from Fakir Mohan Autonomous College and Swami Vivekananda College of Management in Odisha, India.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.